You searched for "safety"
EEG changes following use of cyclopentolate 1% eye drops
Cycloplegic eye drops may affect the central nervous system. This study reports electroencephalogram (EEG) changes in a cohort of 6–15-year-old children. EEG recordings were taken after placebo and two doses of cyclopentolate 1% in 24 awake children (36 children had...
Retrospective analysis on the outcomes of contact lens-associated keratitis in a tertiary centre
This is a retrospective cohort study of 161 eyes (153 patients) with contact lens-associated keratitis (CLAK) from Moorfields Hospital between 1 July 2021 to 28 February 2022. They were classified into three groups based on the size of the epithelial...WATCH EPISODE 3: Beyond 2020 with the Andean Medical Mission
Choosing the right strategy for cataract surgery in countries with developing eyecare services can be difficult. Should you stay in the cities or work more remotely? How remote can you go and still carry out surgery safely. In this episode, Beyond 2020 examines the options.HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children
Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris. Data from an interim analysis of the Observational French Study, OPHTAMYOP, has demonstrated a significant trend of myopia control in children with spherical equivalent...The College of Optometrists publishes updated Clinical Governance Guidance to support quality improvement and excellence in optometry
The College of Optometrists has launched its updated Clinical Governance Guidance to provide members with a robust framework that aligns with the healthcare landscape and primary care optometry workplace practices of today - and into the future. The guidance will...
Intravitreal dexamethasone implant for recurrent CMO secondary to IGS
In this prospective study the authors present the data obtained on the efficacy and safety of the dexamethasone implant (0.7 mg) in the treatment of recurrent cystoid macular oedema (PCME) due to Irvine–Gass syndrome in patients with uncomplicated pseudophakia (off-label...
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...
